Literature DB >> 25946369

Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease.

L V Carreño-Ibáñez1, M D Esteban-Vasallo2, M F Domínguez-Berjón2, J Astray-Mochales2, C González Del Yerro2, D Iniesta-Fornies2, M J Gascón-Sancho2, R Jiménez-García3.   

Abstract

SETTING: Patients aged ⩾ 40 years with a diagnosis of chronic obstructive pulmonary disease (COPD; codes R95, R79 and R91 in the International Classification for Primary Care) registered in primary care clinical records in the Autonomous Community of Madrid, Spain.
OBJECTIVE: To assess pneumococcal vaccination coverage in patients with COPD and to analyse factors associated with vaccination uptake.
DESIGN: Population-based cross-sectional study in which data were collected in September 2010.
RESULTS: We found that 93,797 patients (72.0% men and 28.0% women) had COPD. Overall coverage was 65.5% (67.5% men vs. 60.4% women, P < 0.001). In patients aged 40-59 years, coverage was 19.5%, reaching 75.8% in those aged ⩾ 60 years. In patients aged <60 years, uptake was associated with a higher number of comorbidities and appropriate adherence to seasonal influenza and pandemic vaccination schedules. In patients aged ⩾ 60 years, factors associated with uptake in both sexes were older age and appropriate adherence to seasonal influenza vaccination schedules. Factors associated with uptake in men were concomitant comorbidities and pandemic vaccination.
CONCLUSION: Vaccination coverage in individuals aged <60 years with COPD is less than acceptable in Madrid. Coverage was higher in men and in patients with another chronic condition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25946369     DOI: 10.5588/ijtld.14.0480

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study.

Authors:  Angela Domínguez; Núria Soldevila; Diana Toledo; Pere Godoy; Núria Torner; Luis Force; Jesús Castilla; José María Mayoral; Sonia Tamames; Vicente Martín; Mikel Egurrola; Francisco Sanz; Jenaro Astray
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

Review 2.  Pneumococcal vaccination and chronic respiratory diseases.

Authors:  Filipe Froes; Nicolas Roche; Francesco Blasi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-05

Review 3.  Seasonal influenza vaccination in patients with COPD: a systematic literature review.

Authors:  Rafik Bekkat-Berkani; Tom Wilkinson; Philippe Buchy; Gael Dos Santos; Dimitris Stefanidis; Jeanne-Marie Devaster; Nadia Meyer
Journal:  BMC Pulm Med       Date:  2017-05-03       Impact factor: 3.317

4.  Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink.

Authors:  Anu Jain; Jemma L Walker; Rohini Mathur; Harriet J Forbes; Sinéad M Langan; Liam Smeeth; Albert J van Hoek; Sara L Thomas
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

5.  The efficacy of a flipping education program on improving self-management in patients with chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Yi-Ya Chang; Yu-Tzu Dai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-06-06

6.  A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older.

Authors:  Kenji Kawakami; Atsushi Nakamura; Akira Wakana; Temitope A Folaranmi; Tomoharu Iino
Journal:  Hum Vaccin Immunother       Date:  2019-12-04       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.